Protection against systemic infections with various Candida species elicited by vaccination with Candida albicans ribosomes

REFERENCES

• Braude A.I. Candida and Torulopsis. Medical Microbiology and Infectious Diseases, A.I. Braude. W. B. Saunders, Philadelphia 1981; 643–649, In
   Google Scholar
• Crowle A.J. Delayed hypersensitivity in the mouse. Advances in Immunology, F.Y. Dixon, H.G. Kunkel. Academic Press, New York 1975; 197–264, In
   Google Scholar
• Edwards J.E., Lehrer R.I., Stiehm E.R., Fischer T.J., Young L.S. Severe candidal infections: clinical perspective immune defense mechanisms, and current concepts of therapy. Annals of Internal Medicine 1978; 89: 91–106
   PubMed Web of Science ®Google Scholar
• Hasenclever H.F., Mitchell W.O. Antigenic studies of Candida. II. Antigenic relation of Candida albicans group A and group B to Candida stellatoidea and Candida tropicalis. Journal of Bacteriology 1961; 82: 574–577
   PubMed Web of Science ®Google Scholar
• Hasenclever H.F., Mitchell W.O. Antigenic studies of Candida. III. Comparative pathogenicity of Candida albicans group A, group B and Candida Stellatoidea. Journal of Bacteriology 1961; 82: 578–581
   PubMed Web of Science ®Google Scholar
• Holzschu D.L., Chandler F.W., Ajello L., Ahearn D.G. Evaluation of industrial yeasts for pathogenicity. Sabouraudia 1979; 17: 71–78
   PubMedGoogle Scholar
• Hurley R. Pathogenicity of the genus Candida. Symposium on Candida Infections, H.I. Winner, R. Hurley. E. & S. Livingstone, Edinburgh 1966; 13–25, In
   Google Scholar
• Hurley R., Stanley V.C. Cytopathic effects of pathogenic and non-pathogenic species of Candida on cultured mouse epithelial cells: relation of the growth rate and morphology of the fungi. Journal of Medical Microbiology 1979; 2: 63–74
   Web of Science ®Google Scholar
• Levy R., Segal E., Eylan E. Protective immunity against murine candidiasis elicited by Candida albicans ribosomal fractions. Infection and Immunity 1981; 31: 874–878
   PubMed Web of Science ®Google Scholar
• Levy R., Segal E., Eylan E., Barr-Nea L. Cell mediated immunity following experimental vaccinations with Candida albicans ribosomes. Mycopathologia 1983; 83: 161–168
   PubMed Web of Science ®Google Scholar
• Levy R., Segal E., Eylan E. Detection of antibodies against Candida albicans ribosomes by the enzyme linked immunosorbent assay. Mycopathologia 1984; 87: 167–170
   PubMed Web of Science ®Google Scholar
• Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the folin phenol reagent. Journal of Biological Chemistry 1951; 193: 265–275
   PubMed Web of Science ®Google Scholar
• Meunier-Carpentier F., Kiehn T.E., Armstrong D. Fungemia in the immunocompromised host: changing patterns, antigenemia, high mortality. American Journal of Medicine 1981; 71: 363–370
   PubMed Web of Science ®Google Scholar
• Odds F.C. Candida and Candidosis. University Par, Press, Baltimore 1979
   Google Scholar
• Oppenheim J.J., Rosenstreich D.L. Lymphocyte transformation: utilization of automatic harvesters. In Vitro Methods in Cell Mediated and Tumor Immunology, B. Bloom, R. David. Academic Press, New York 1976; 573–585, In
   Google Scholar
• Rippon J.W. Medical Mycology. The Pathogenic Fungi and the Pathogenic Actinomyctes. W. B. Saunders, Philadelphia 1982; 484–532
   Google Scholar
• Schalla W.O., Johnson W. Immunogenicity of ribosomal vaccines isolated from group A, type 14, Streptococcus pyogenes. Infection and Immunity 1975; 11: 1196–1202
   Web of Science ®Google Scholar
• Segal E., Eylan E. Genetic relatedness of Candida albicans to asporogenous and ascosporogenous yeasts as reflected by nucleic acid homologies. Microbios 1974; 9: 25–33
   PubMedGoogle Scholar
• Segal E., Levy R., Eylan E. Antibody formation in experimental immunization with Candida albicans ribosomal fractions. Mycopathologia 1978; 64: 121–123
   PubMed Web of Science ®Google Scholar
• Segal E., Levy R., Eylan E. Experimental immunization with Candida albicans ribosomal fractions: protection and immunological aspects. Human and Animal Mycology, E. Kuttin, G. Baum. Excerpta Medica, Amsterdam 1980; 114–117, In
   Google Scholar
• Stenderup A., Leth, Bak A. Deoxyribonucleic acid base composition of some species within the genus Candida. Journal of General Microbiology 1968; 52: 231–236
   Google Scholar
• Thomas D.W., Weiss E. Response of mice to injection of ribosomal fraction from group B Neiseria meningitidis. Infection and Immunity 1972; 6: 344–363
   PubMed Web of Science ®Google Scholar
• Tsuchiya T., Fukazawa Y., Kawakita S. Serological classification of the genus Candida. Studies on Candidiasis in Japan. Education Ministry of Japan, Tokyo 1961; 34–46, In
   Google Scholar
• Wingard J.R., Merz W.G., Saral R. Candida tropicalis: a major pathogen in immunocompromised patients. Annals of Internal Medicine 1979; 91: 539–543
   PubMed Web of Science ®Google Scholar
• Wingard J.R., Dick J.D., Merz W.G., Sandford G.R., Saral R., Busus W.H. Pathogenicity of Candida tropicalis and Candida albicans after gasteroinstestinal inoculation in mice. Infection and Immunity 1980; 29: 808–813
   PubMed Web of Science ®Google Scholar